Reduced neuronal co-localisation of nardilysin and the putative α-secretases ADAM10 and ADAM17 in Alzheimer’s disease and Down syndrome brains
- 30 August 2008
- journal article
- research article
- Published by Springer Nature in AGE
- Vol. 31 (1) , 11-25
Abstract
The peptidase nardilysin is involved in degradation of neuropeptides and limited intracellular proteolysis. Recent reports point to an involvement of nardilysin in the pathophysiology of Alzheimer’s disease. Nardilysin enhances the α-secretase activity of the disintegrin and metalloproteases (ADAMs) 10 and 17, thereby possibly contributing to reduced generation of amyloidogenic fragments from the amyloid precursor protein. A prerequisite for the α-secretase-stimulating effect of nardilysin on the activity of ADAMs in vivo is cellular co-expression of nardilysin with ADAM10 and/or ADAM17. We immunolocalised nardilysin, ADAM10, and ADAM17 in cortical regions of normal aged brain, in Alzheimer’s disease, and in Down syndrome brains and counted the number of protease-expressing neurons. A considerable portion of neurons co-express nardilysin together with either ADAM10 or ADAM17. Compared to controls, in Alzheimer’s disease and in Down syndrome brains there is a decreased cellular expression of all three antigens, and a reduction in the number of those neurons that co-express nardilysin with ADAM10 or with ADAM17. Our data are consistent with the notion that the proposed α-secretase-enhancing activity of nardilysin might play a role in human brain pathology.Keywords
This publication has 56 references indexed in Scilit:
- Ectodomain shedding of TNF-α is enhanced by nardilysin via activation of ADAM proteasesBiochemical and Biophysical Research Communications, 2008
- ADAM-10 over-expression increases cortical synaptogenesisNeurobiology of Aging, 2008
- Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brainNeurobiology of Aging, 2007
- New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing α‐secretase activityEuropean Journal of Neuroscience, 2007
- Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer's disease brainNeurochemistry International, 2006
- The Glucagon–Miniglucagon InterplayAnnals of the New York Academy of Sciences, 2006
- The ADAMs family: Coordinators of nervous system development, plasticity and repairProgress in Neurobiology, 2006
- Altered expression of protein p42IP4/centaurin-α1 in Alzheimer’s disease brains and possible interaction of p42IP4 with nucleolinNeuroReport, 2004
- Coordinated Expression of β‐Amyloid Precursor Protein and the Putative β‐Secretase BACE and α‐Secretase ADAM10 in Mouse and Human BrainJournal of Neurochemistry, 2000
- Families of zinc metalloproteasesFEBS Letters, 1994